Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX +2.18% rallied 1.58% to $95.18 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.13% rising 0.75% to 14,346.00 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.56% rising 0.78% to 35,405.24. This was the stock's third consecutive day of gains. Novavax Inc. closed $236.50 short of its 52-week high ($331.68), which the company reached on February 9th.
The stock outperformed some of its competitors Tuesday, as Replimune Group Inc. /zigman2/quotes/203971249/composite REPL -2.39% fell 2.32% to $19.37, VBI Vaccines Inc. /zigman2/quotes/201705917/composite VBIV -1.40% rose 1.18% to $1.72, and AnaptysBio Inc. /zigman2/quotes/205822596/composite ANAB -1.27% fell 0.31% to $31.87. Trading volume (7.1 M) eclipsed its 50-day average volume of 6.6 M.